Landos Biopharma Announces FDA Clearance of its IND for LABP-104 for the Treatment of Rheumatoid Arthritis
Phase 1 trial is underway with topline results expected in the first half of 2022 Represents Landos’ seventh IND cleared...
Month: November 2021
ECAM Council 2nd edition ‘Finding New Ways to Care’ brought in high profile global leaders to Rome
An Urgent Call to Support Healthcare Investment in Public-Private Initiatives Delegates at the second edition of ECAM – The European...
Akoya Biosciences Announces Founding Members of First-of-its-Kind Imaging Innovators (I²) Network
CODEX Brain Tissue Image CODEX staining of a human brain tissue sample reveals the presence of biomarkers that enable researchers...
Evolus Reports Third Quarter 2021 Results and Provides Business Update
Record Quarter: U.S. Net Revenue Grew 58% Year-over-Year to $26.7 Million$107.8 Million Cash Position at Quarter-EndInitiated Jeuveau® “Extra Strength” Phase...
Evolus Initiates Phase II Program with “Extra Strength” Dose for Extended Duration
Program Designed to Offer Consumers an “Extra Strength” Dosing OptionEvolus is Uniquely Positioned to Capitalize on this Opportunity with the...
Inspire Medical Systems, Inc. to Present at the Stifel 2021 Virtual Healthcare Conference
MINNEAPOLIS, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on...
Ikena Oncology Announces FDA Acceptance of IND Application of Novel TEAD Inhibitor IK-930
Ikena expects to initiate its first-in-human phase 1 clinical trial in early 2022 in patients with solid tumors that harbor...
Intra-Cellular Therapies to Host Third Quarter 2021 Financial Results Conference Call and Webcast
NEW YORK, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and...
Galecto Announces Clinical Collaboration with Roche for Phase 2 Trial of GB1211 in Combination with Atezolizumab in First Line Non-Small-Cell Lung Cancer
Upcoming Phase 2 trial marks expansion of Galecto pipeline into oncology and provides opportunity for exploring the use of galectin-3...
Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome
As an element of Nautilus’ overall reagent development and sourcing strategy, the partnership aims to accelerate research and development, and...
Prometheus Biosciences to Present at Upcoming Investor Conferences
SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision...
AGTC to Host First Quarter Financial Results Conference Call and Webcast on November 9, 2021
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company...
Candel Therapeutics to Participate in Three Upcoming Investor Conferences
NEEDHAM, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Nasdaq: CADL), a late clinical stage biopharmaceutical company developing...
Intercept Announces Late-Breaking Oral Presentation and Poster Presentations at The Liver Meeting
Late-breaking oral presentation compares transplant-free survival in patients with PBC treated with OCA to external controls from the Global PBC...
Beyond Air® to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
GARDEN CITY, N.Y., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical...
Immutep Granted Chinese Patent for Eftilagimod Alpha, a Soluble Lag-3 Protein, in Combination with a Chemotherapy Agent
SYDNEY, AUSTRALIA, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology...
Histogen and Amerimmune Announce the Presentation of Emricasan Data in COVID-19 at the American College of Allergy, Asthma, and Immunology Conference
Phase 1 Study in Mild COVID-19 Patients Demonstrated a Favorable Safety and Tolerability Profile and Statistically Significant Clinical Symptom and...
Lonza to Acquire Codiak BioSciences Exosomes Manufacturing Facility and Establish a Long-Term Strategic Collaboration
Lonza to acquire and operate Codiak's Lexington, MA (US) facility and become the strategic manufacturing partner for Codiak’s pipelineLonza and...
Healthcare Triangle Announces the appointment of Manish Hindupur as Vice President, Cloud Service Delivery for Life Sciences and Healthcare Providers
PLEASANTON, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Healthcare Triangle Inc., (Nasdaq: HCTI) (“HCTI” or the "Company") a leading provider...
The Texas Liver Institute Participating in RESPONSE, a Global Phase 3 Clinical Research Study Evaluating an Investigational Therapy for the Treatment of Primary Biliary Cholangitis (PBC)
Novel oral medication could provide a new treatment option for people with PBC who have not achieved the recommended treatment...
